Health News: [diabetes ]: MannKind's Afrezza fares well in late-stage trials

Yahoo! Health   |  My alerts   |   Edit Alert Wednesday, Aug 14, 2013 08:11 AM EDT

Health News : diabetes - News from Yahoo !   MannKind diabetes therapy succeeds in studies; shares surge Wed, 14 Aug, 2013 04:31 AM PDT (Reuters) - MannKind Corp said results of two late-stage studies showed that its experimental diabetes therapy was more effective than injected insulin and oral treatments, sending its shares up 30 percent in premarket trading. The drug-device combination, called Afrezza, consists of insulin powder loa... Continue reading

Health News : diabetes - Top images.

Health News : diabetes - News from other sources.   MannKind's Afrezza fares well in late-stage trials Wed, 14 Aug, 2013 05:08 AM PDT (AP) — Drug developer MannKind says its inhaled insulin Afrezza met the main goals behind two late-stage studies involving patients with two types of diabetes. The Valencia, Calif., company says type 2 diabetes patients taking Afrezza and the widely used generic drug metformin saw better reducti... Continue reading Border health conference set for Aug. 23 Wed, 14 Aug, 2013 05:08 AM PDT Laredo and other counties on the U.S.-Mexico border have some of the highest levels of poverty, lack of insurance, diabetes and obesity in the country, according to U.S. Congressman Henry Cuellar. Continue reading MannKind's inhaled insulin Afrezza meets goals in 2 late-stage studies of diabetes patients Wed, 14 Aug, 2013 04:37 AM PDT VALENCIA, Calif. — Drug developer MannKind says its inhaled insulin Afrezza met the main goals behind two late-stage studies involving patients with two types of diabetes. Continue reading Sanford-Burnham, Pfizer collaborates to identify therapeutic targets for treating obesity, diabetes Wed, 14 Aug, 2013 04:23 AM PDT Sanford-Burnham Medical Research Institute (Sanford-Burnham) announced that it has entered into a collaboration with Pfizer Inc. to identify new therapeutic targets for preventing and treating complications of obesity and diabetes. Continue reading All Systems Broadband Sponsors "Summer Classic" Wed, 14 Aug, 2013 04:16 AM PDT Company Focuses on Helping to Find a Cure for Type 1 Diabetes (PRWeb August 14, 2013) Read the full story at http://www.prweb.com/releases/2013/8/prweb11025114.htm Continue reading Mediterranean diet may help counteract genetic risk of stroke Wed, 14 Aug, 2013 04:02 AM PDT Washington, August 14 : Researchers have claimed that a gene variant, strongly linked with the development of type 2 diabetes, seems to interact with Mediterranean diet - featuring olive oil, fish, complex carbohydrates and nuts - to prevent stroke. Continue reading Fundraiser planned for Delaney Brown who's battling leukemia Wed, 14 Aug, 2013 03:18 AM PDT Community members in Berks County are gathering support for a little girl with leukemia. "It was the most devastating thing to hear," said Jennifer Capone-Brown. That is Jennifer Capone-Brown recounting the moment she found out her seven-year old daughter had leukemia. Delaney Brown was initially diagnosed wi... Continue reading Conversant Bio Releases Comprehensive Diabetes Research Reference E-Book Wed, 14 Aug, 2013 03:18 AM PDT New guide offers information to help researchers better understand the disease and accelerate drug discovery efforts. (PRWeb August 14, 2013) Read the full story at http://www.prweb.com/releases/conversant-bio/diabetes-research/prweb11019542.htm Continue reading MannKind Reports Positive Data from a Phase 3 Clinical Study of AFREZZA in Patients with Type 2 Diabetes Wed, 14 Aug, 2013 03:15 AM PDT VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD) today announced positive preliminary results from Study 175, a Phase 3 clinical study of AFREZZA® (insulin human [rDNA origin]) Inhalation Powder, an investigational, ultra rapid-acting mealtime insulin therapy administered using MannKind'... Continue reading

You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.